These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2529801)
1. Atrial natriuretic peptide levels and pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Wang TS; Duan SF; Zhang ZQ; Xu YJ Am Rev Respir Dis; 1989 Oct; 140(4):1173. PubMed ID: 2529801 [No Abstract] [Full Text] [Related]
2. Human atrial natriuretic peptide secretion in precapillary pulmonary hypertension. Clinical study in patients with COPD and interstitial fibrosis. Burghuber OC; Hartter E; Punzengruber C; Weissel M; Woloszczuk W Chest; 1988 Jan; 93(1):31-7. PubMed ID: 2961514 [TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Adnot S; Chabrier PE; Andrivet P; Viossat I; Piquet J; Brun-Buisson C; Gutkowska Y; Braquet P Am Rev Respir Dis; 1987 Oct; 136(4):951-6. PubMed ID: 2959183 [TBL] [Abstract][Full Text] [Related]
4. [Relation of the plasma level of atrial natriuretic peptide and hemodynamic parameters in patients with chronic obstructive pulmonary disease]. Wang T Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):148-50. PubMed ID: 2163741 [No Abstract] [Full Text] [Related]
14. Atrial natriuretic peptide is a regulator of pulmonary vascular tone. A hypothesis. Westendorp RG; Roos AN; Meinders AE Neth J Med; 1990 Dec; 37(5-6):167-70. PubMed ID: 2150094 [No Abstract] [Full Text] [Related]
15. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. Tsutamoto T; Kanamori T; Wada A; Kinoshita M J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959 [TBL] [Abstract][Full Text] [Related]
16. The natriuretic peptides. Clinical applications in patients with COPD. Klinger JR; Cutaia M Chest; 1996 Nov; 110(5):1136-8. PubMed ID: 8915207 [No Abstract] [Full Text] [Related]
17. [Influence of mixed venous blood PO2 on the pulmonary arterial pressure in chronic obstructive pulmonary disease (COPD): correlations in 128 patients]. Geraads A; Pirotte C; Rigaud D; Ligeonnet D; Paramelle B Poumon Coeur; 1983; 39(5):221-7. PubMed ID: 6657548 [TBL] [Abstract][Full Text] [Related]
18. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Nagaya N; Nishikimi T; Uematsu M; Kyotani S; Satoh T; Nakanishi N; Matsuo H; Kangawa K Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693 [TBL] [Abstract][Full Text] [Related]
19. Plasma levels of atrial natriuretic factor, renin activity, and aldosterone in patients with chronic obstructive pulmonary disease. Response to O2 removal and to hyperoxia. Adnot S; Andrivet P; Chabrier PE; Defouilloy C; Viossat I; Braquet P; Atlan G; Brun-Buisson C Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1178-84. PubMed ID: 2140252 [TBL] [Abstract][Full Text] [Related]
20. Vascular and cardiac reactivity in pulmonary hypertension due to chronic obstructive lung disease: assessment with various oxygen concentrations. Saadjian A; Philip-Joët F; Levy S; Arnaud A Eur Respir J; 1992 May; 5(5):525-30. PubMed ID: 1612153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]